The Worldwide HCP Social Media Study

If you like this presentation – show it...

Slide 0

Digital Opinion Leaders in Diabetes The Worldwide HCP Social Media Study Daniel Ghinn, Creation Healthcare @EngagementStrat Special Event Edition with Exclusive Pharma Insights

Slide 1

Diabetes in 2013-14 The global burden and threat of NCDs constitutes a major public health challenge that undermines social and economic development throughout the world… World Health Organization, Global Action Plan for the Prevention & Control of Noncommunicable Diseases 2013-2020 By the end of 2013, diabetes will have caused 5.1 million deaths and cost USD 548 billion in healthcare spending. Without concerted action to prevent diabetes, in less than 25 years’ time there will be 592 million people living with the disease. Most of those cases would be preventable. International Diabetes Federation, IDF Diabetes Atlas, 6th Edition, 2013 Diabetes is a huge and growing problem, and the costs to society are high and escalating.

Slide 2

Learning from Healthcare Professionals A distilled view of public social media conversations 70M+ websites Full Twitter ‘Firehose’ feed All major social media >100,000 verified healthcare professional (HCP) sources covering websites & social media

Slide 3

8,189,534 People connected to HCPs in the study 47,875 HCPs connected to diabetes conversation 205,889 HCP Tweets & posts about diabetes 19,068 HCP authors in study 189,402 HCP Tweets about diabetes 16,896 HCPs Tweeting about diabetes Big Data: impact of Healthcare Professionals

Slide 4

Most conversation is about Type 2 Diabetes n=27,017 Most HCP conversation about diabetes does not refer explicitly to a diabetes type, but implies Type 2.

Slide 5

>300 HCP Roles

Slide 6

Top 15 HCP roles by share of voice of >300 HCP roles in study

Slide 7

>200,000 posts; 19,000 HCPs in >125 countries n=16,896

Slide 8

HCP networks within networks n=16,896

Slide 9

Most influential endocrinologists – virtual network

Slide 10

Relationship matters Relationship matters A virtual professional network connected by diabetes Endocrinologists discussing diabetes online

Slide 11

HCP: Activism for patients Partha Kar is also the most engaged HCP by peers in diabetes Activating

Slide 12

Multi-dimensional data

Slide 13

Time & role: what the data tells us

Slide 14

Global diabetes timeline The story told by HCPs in social media All HCP conversation

Slide 15

Global diabetes timeline: Roles Endocrinologists

Slide 16

News: Fall in diabetes-related deaths “Good news: the risk of dying early due to diabetes has been greatly reduced! … The treatment helps!” 17-23 June 2013 Physician, Researcher & Writer Norway Optimistic

Slide 17

News: Fall in diabetes-related deaths – sceptics? 17-23 June 2013 General Practitioner & Blogger UK Questioning Sceptical

Slide 18

Global diabetes timeline: Roles Endocrinologists

Slide 19

News: Roche halts trial of diabetes drug 8-14 July 2013 Frustrated

Slide 20

News: Roche halts trial of diabetes drug – mixed reactions 8-14 July 2013 Indifferent Concerned

Slide 21

Global diabetes timeline: Roles Endocrinologists

Slide 22

Global diabetes timeline: Roles Leadership roles

Slide 23

Global diabetes timeline: Roles Neurosurgeons

Slide 24

Global diabetes timeline: Roles Registered Nurses

Slide 25

Global diabetes timeline: Roles Dieticians

Slide 26

Multi-dimensional data

Slide 27

Time & topics: what the data tells us

Slide 28

Global diabetes timeline: Topics by patient age group HCP conversation about all diabetes topics

Slide 29

USPSTF backs universal diabetes testing for pregnant women “Interesting that the US Preventive Services Task force now recommends what has been the standard of care for years.” 13-19 January 2014 Supportive Frustrated Cynical Interpreting

Slide 30

Diabetes testing for pregnant women - Japan “Doctor Song Mingyuan said that there were some gynaecologists who didn’t do their jobs properly, such as not conducting examinations for gestational diabetes, and it’s true. We recently got someone from a place like this, which does so little pregnancy examinations, it’s ridiculous. For blood samples, all they do for early stage examinations is check for infectious diseases and do a red blood cell count, and then for mid stage examinations, they just check for casual blood glucose. And then they just go home. Come on, seriously, stop it.” 13-19 January 2014 Frustrated

Slide 31

Multi-dimensional data

Slide 32

Place & topics: what the data tells us

Slide 33

Geography matters Key topics around prevention, diagnosis & management vary by country

Slide 34

Diabetes in multiple dimensions

Slide 35

Insights for Pharma

Slide 36

HCPs who talk about diabetes and pharma brands

Slide 37

HCP mentions of pharmaceutical companies & products HCP conversation about all diabetes topics 300 200 100

Slide 38

HCP roles discussing GSK products over time 300 200 100

Slide 39

GSK & products global picture – map of HCPs

Slide 40

GSK examples Sensational Alarmed Sharing Shocked? Balancing

Slide 41

Avandia FDA review – live updates via social media Highlighting Observing Observing Sensational Sharing Frustrated

Slide 42

Avandia – the feedback Warning Encouraging Warning Warning

Slide 43

Reaction turns more positive Supportive Supportive Hopeful Empathetic Encouraging

Slide 44

Changing attitudes in HCP conversation 300 200

Slide 45

What next? Dive deeper: Questions about this study? daniel.ghinn@creationhealthcare.com @EngagementStrat www.creationhealthcare.com